Physician profile
Richard Stuart Eason
NPI 1205800331
$808.48
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $105 · 2021: $146 · 2022: $171 · 2023: $71.87 · 2024: $50.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.09 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $120.98 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $109.64 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.74 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $89.30 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $76.11 | 2020-2021 | |
| Alcon Vision LLC | $64.93 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $50.06 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $37.21 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $34.93 | 2022-2023 | Miebo |
| Oyster Point Pharma, INC. | $25.61 | 2022 | |
| Rxsight INC | $21.82 | 2022 | |
| New World Medical,INC. | $20.91 | 2023 | |
| Thea Pharma INC. | $17.95 | 2023 | |
| Boston Scientific Corporation | $16.12 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $15.17 | 2023 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Eason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.